Home > News > Do-Coop Technologies Announces New Product
March 30th, 2006
Do-Coop Technologies Announces New Product
Abstract:
Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the commercial availability of Neowater(TM) - ELISA Enhancer, a new product that increases immunoassay sensitivity and accuracy, while reducing total reaction costs. As with the entire Neowater-based product line, the ELISA Enhancer product is also generic, simple to use, and can be easily incorporated into any type of immunoassays with dramatic results.
Source:
businesswire
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||